Financial Performance - The company's revenue for Q3 2021 reached ¥695,584,493.01, representing a year-on-year increase of 21.29%[4] - The net profit attributable to shareholders decreased by 14.71% to ¥54,298,187.00 for the same period[4] - The net profit after deducting non-recurring gains and losses was ¥53,673,430.00, down 13.60% year-on-year[4] - Total operating revenue for the period reached CNY 1,951,892,550.57, an increase of 16.2% compared to CNY 1,680,165,107.47 in the previous period[24] - Net profit for the period was CNY 133,378,172.65, a decrease of 26.2% from CNY 180,772,463.95 in the same period last year[25] - Earnings per share decreased to CNY 0.30 from CNY 0.42, reflecting a decline of 28.6%[25] Assets and Liabilities - The total assets increased by 17.90% to ¥2,675,530,098.41 compared to the end of the previous year[4] - Total assets increased to CNY 2,675,530,098.41, compared to CNY 2,269,233,836.41 in the previous year, representing a growth of 17.9%[23] - Total liabilities rose to CNY 371,748,369.30, up from CNY 346,267,223.09, indicating a growth of 7.4%[23] - Owner's equity increased to CNY 2,303,781,729.11, compared to CNY 1,922,966,613.32, marking a rise of 19.8%[23] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥167,243,819.23, a decrease of 36.83%[11] - Operating cash inflow for the current period reached CNY 2,239,837,444.38, a 36.7% increase from CNY 1,639,184,749.34 in the previous period[27] - Net cash flow from operating activities was CNY 167,243,819.23, down 37% from CNY 264,736,932.32 year-on-year[27] - Cash inflow from financing activities was CNY 283,127,358.50, compared to CNY 12,218,315.31 in the previous period, leading to a net cash inflow of CNY 245,556,254.94[28] - The ending balance of cash and cash equivalents decreased to CNY 66,615,606.88 from CNY 231,221,017.50 in the previous period[28] Investments and Expenses - Research and development expenses surged by 162.52% to ¥22,469,831.37, reflecting increased investment in new product development[10] - Research and development expenses were CNY 22,469,831.37, significantly higher than CNY 8,559,147.17 in the previous period, reflecting an increase of 162.5%[24] - Cash outflow for investment activities totaled CNY 612,679,504.88, significantly higher than CNY 104,016,630.52 in the previous period, resulting in a net cash outflow of CNY 549,586,866.85[28] - The company paid CNY 201,796,024.50 for the acquisition of fixed assets, intangible assets, and other long-term assets[28] Shareholder Information - The company has a total of 10 major shareholders, with the largest being Jinan Lumin Investment with a 13.18% stake[14] - The company has committed to a lock-up period for certain shares, with 61,338,778 shares held by Zhao Dongri remaining locked during his tenure[16] - The company issued 45,000,000 shares at a price of CNY 6.38 per share, raising a total of CNY 287,100,000, with a net amount of CNY 283,127,358.50 after deducting issuance costs[18] Operational Highlights - The company reported a significant increase of 318.00% in trading financial assets, totaling ¥460,000,000.00[8] - The company reported a significant increase in trading financial assets, which rose to CNY 460,000,000.00 from CNY 110,000,000.00, a growth of approximately 318.2%[21] - The company experienced a cash outflow of CNY 79,496,052.59 for employee compensation, slightly up from CNY 73,614,074.81[27] - The company reported a significant increase in cash received from sales, totaling CNY 2,208,966,949.57, compared to CNY 1,530,626,378.34 in the previous period[27] Audit and Compliance - The company did not undergo an audit for the third-quarter report[29]
日科化学(300214) - 2021 Q3 - 季度财报